Prohibits investment by State of pension and annuity funds in Chinese pharmaceutical companies.

This bill (A 2658) prohibits New Jersey's state pension and annuity funds from investing in Chinese pharmaceutical companies or any company with business ties to them. It directly affects the state's pension funds managed by the Division of Investment, requiring them to divest existing holdings within three years. Key mechanisms include annual reporting to the legislature on divestment progress and requiring the State Investment Council to consult with an independent research firm to identify affected investments. The bill is pending before the New Jersey Assembly (introduced January 13, 2026) and does not yet take effect.